You are here: Industry Insights > Cell Therapy

News List

G-CON Manufacturing Delivers & Installs PODs for Cell Therapy Manufacturing contractpharma
February 20, 2021
G-CON Manufacturing, a leader in prefabricated, flexible cleanroom solutions, has successfully delivered and installed three PODs to a clinical-stage immuno-oncology company for cell therapy manufacturing.
Catalent, Trizell Enter Cell Therapy Deal contractpharma
February 09, 2021
Catalent has signed an agreement with Trizell GmbH, to support the manufacturing of Trizell’s Phase 1 cell therapy for the treatment of micro- and macroangiopathies.
Bone Therapeutics, Rigenerand Ink Cell Therapy Deal contractpharma
January 20, 2021
Bone Therapeutics, a cell therapy company addressing unmet medical needs in orthopedics and other diseases, and Rigenerand SRL, a biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for ...
Immuneel sets up cell therapy development and production facility in Narayana Hrudayalaya Health City, Bengaluru expresspharma
January 19, 2021
The facility will currently focus on autologous cell therapies including CAR-T cell therapy for lymphomas and leukaemias.
Gracell Biotechnologies Announces Presentation of First-in-Human Data of GC012F a First-in-Class FasTCAR-enabled Dual-targeting BMCA/CD19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Mu prnasia
December 07, 2020
Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced an interim readout to evaluate the safety and efficacy of ...
Regenerative medicine market to reach $16.4 bn in 2026: GlobalData expresspharma
December 07, 2020
There are currently 53 marketed RM products and 175 RM pipeline agents in development in the eight major markets.
Catalent completes acquisition of Bone Therapeutics’ cell therapy manufacturing subsidiary SCTS expresspharma
November 17, 2020
Catalent Pharma Solutions has completed the acquisition of Bone Therapeutics’ manufacturing subsidiary, Skeletal Cell Therapy Support SA (SCTS), announced on 29 October 2020.
Leading Cell Therapy Company JW Therapeutics Lists on Main Board of HKEX prnasia
November 04, 2020
JW Therapeutics today celebrates the initial public offering (IPO) on the Main Board of the Stock Exchange of Hong Kong, S.A.R., China Limited.
CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates prnasia
November 04, 2020
CARsgen Therapeutics Holdings Limited, a leading biotechnology company focused on innovation and development of chimeric antigen receptor (CAR) T-cell therapeutics, announced the completion of a USD 186 million Series C Equity Financing.
iBio Enters into Agreement with Safi Biosolutions contractpharma
October 10, 2020
iBio, a biotech innovator and biologics contract manufacturing organization (CMO), has entered into a Master Services Agreement (MSA) with Boston-based Safi Biosolutions to evaluate iBio’s FastPharming System for the expression of key proteins to be ...

Previous page 1 2 3 4 5 6 7 8 Next page